Note 4 - Acquisition (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Business Acquisition, Pro Forma Information [Table Text Block]

	For the Three Months Ended September 30, 2023		For the Three Months Ended September 30, 2022
	(Unaudited)		(Unaudited)
Revenue	$	15,290,000	$	12,775,000
Earnings	$	4,076,000	$	(13,777,000	)

	For the Nine Months Ended September 30, 2023			For the Nine Months Ended September 30, 2022
	(Unaudited)			(Unaudited)
Revenue	$	44,071,000		$	39,248,000
Earnings	$	(6,219,000	)	$	(16,511,000	)

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

	Purchase Price Allocation
Total purchase consideration	$	11,465,000
Fair value of non-controlling interest		15,957,000
Total consideration	$	27,422,000
Identifiable net assets acquired - Provisional:
Cash	$	7,352,000
Accounts receivable, net		6,478,000
Accounts receivable, other		506,000
Inventory		1,631,000
Prepaid expenses		220,000
Property and equipment, net		2,883,000
Right of use assets, net		405,000
Intangible assets, net:
Trade name		4,060,000
Development technology		2,560,000
Pharmacy records		8,100,000
Other		-
Deposits		39,000
Accounts payable and accrued expenses		(8,196,000	)
Notes payable and accrued interest - current portion		(149,000	)
Lease liabilities - current portion		(208,000	)
Notes payable - long term		(1,173,000	)
Lease liabilities - long term		(230,000	)
Net assets acquired	$	24,278,000
Goodwill	$	3,144,000